Degradation of AZGP1 suppresses apoptosis and facilitates cholangiocarcinoma tumorigenesis via TRIM25
Journal of Cellular and Molecular Medicine · 2024-02 · 28 (3)
DOI: 10.1111/jcmm.18104 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 06.01.2024. Verfasst von Hyeseon Yun und 9 weiteren Autor:innen. Beteiligte Einrichtung: Asan Institute for Life Science, Asan Medical Center, Seoul, Korea. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Bile Duct Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Alpha‐2‐Glycoprotein 1, Zinc‐binding (AZGP1, ZAG) is a secreted protein that is synthesized by adipocytes and epithelial cells; it is downregulated in several malignancies such as breast, prostate, liver and lung cancers. However, its function remains unclear in cholangiocarcinoma (CCA). Here, we evaluated the impact AZGP1 in CCA using Gene Expression Omnibus (GEO) and GEPIA. In addition, we analysed AZGP1 expression using quantitative reverse transcription PCR and western blotting. Expression of AZGP1 was nearly deficient in CCA patients and cell lines and was associated with poor prognosis. AZGP1 overexpression upregulated apoptosis markers. Co‐immunoprecipitation experiments showed that AZGP1 interacts with tripartite motif‐containing protein 25 (TRIM25), and tissue microarray and bioinformatic analysis showed that AZGP1 is negatively correlated with TRIM25 expression in CCA. Thereafter, TRIM25 knockdown led to AZGP1 upregulation and induced cancer cell apoptosis. TRIM25 targets AZGP1 for degradation by catalysing its ubiquitination. AZGP1 overexpression significantly suppressed tumour growth in a xenograft mouse model. This study findings suggest that AZGP1 is a potential therapeutic target or a diagnostic biomarker for treating patients with CCA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Asan Institute for Life Science, Asan Medical Center, Seoul, Korea.
- Department of Pharmacology, AMIST, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
- Department of Convergence Medicine, Asan Institute for Life Science, Asan Medical Center, Seoul, Korea.
ORCID-Profile: Dong-Hoon Jin
Zitieren
APA
Yun, H., Jeong, H. R., Kim, D. Y., You, J. E., Lee, J. U., Kang, D. H., Koh, D. I., Ryu, Y. S., Bae, S., & Jin, D. H. (2024). Degradation of AZGP1 suppresses apoptosis and facilitates cholangiocarcinoma tumorigenesis via TRIM25. Journal of Cellular and Molecular Medicine, 28(3). https://doi.org/10.1111/jcmm.18104
Vancouver
Yun H, Jeong HR, Kim DY, You JE, Lee JU, Kang DH, et al. Degradation of AZGP1 suppresses apoptosis and facilitates cholangiocarcinoma tumorigenesis via TRIM25. Journal of Cellular and Molecular Medicine. 2024;28(3). doi:10.1111/jcmm.18104
BibTeX
@article{Yun2024,
author = {Yun, Hyeseon and Jeong, Hong-Rae and Kim, Do Yeon and You, Ji-Eun and Lee, Ji-U and Kang, Dong-Hee and Koh, Dong-In and Ryu, Yea Seong and Bae, SeungGeon and Jin, Dong-Hoon},
title = {Degradation of AZGP1 suppresses apoptosis and facilitates cholangiocarcinoma tumorigenesis via TRIM25},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
volume = {28},
number = {3},
doi = {10.1111/jcmm.18104}
}
EUVIMED